Daniela Calabrese

Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial

Davide Pareyson, Mary M. Reilly, Angelo Schenone et al. · The Lancet Neurology · 2011 · 260 citations · Full text

Medicine, Ascorbic Acid, Dental Disease +1

Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes

Andrea Cortese, Yi Zhu, Adriana Rebelo et al. · Nature Genetics · 2020 · 170 citations · Full text

Biallelic Mutations, Somatic Variant, Genetic Disorder +9

Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area

Andrea Cortese, Giuseppe Vita, Marco Luigetti et al. · Journal of Neurology · 2016 · 96 citations

Alzheimer's Disease, Longitudinal Multicenter Study, Non-endemic Area +4

Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study

Menelaos Pipis, Shawna Feely, James M. Polke et al. · Brain · 2020 · 87 citations · Full text

ATTRv amyloidosis Italian Registry: clinical and epidemiological data

Massimo Russo, Laura Obici, Ilaria Bartolomei et al. · Amyloid · 2020 · 84 citations